Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
Go back to Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04| (NASDAQ: ADIL) | Delayed: 4.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.31 | 52 Week High | $ | |||
| Open | $4.36 | 52 Week Low | $ | |||
| Day High | $4.49 | P/E | N/A | |||
| Day Low | $4.11 | EPS | $ | |||
| Volume | 64,782 | |||||

